Merck & Co., Inc. (MRK) vs Micron Technology, Inc. (MU)
See how Merck & Co., Inc. and Micron Technology, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$152.2
NYSE
Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.
View Full Page$937.11
NasdaqGS
Key Metrics Comparison
Merck & Co., Inc.MRK
Market Cap$375.504B
Price$152.2
24h Change+12.60%
24h Volume$32.55M
Employees73,000
Shares Outstanding2,469,879,206
Micron Technology, Inc.MU
Market Cap$1.058T
Price$937.11
24h Change-0.39%
24h Volume$25.69M
Employees53,000
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
MRK
26.2%MU
73.8%Volume Share
Share of combined 24h volume
MRK
55.9%MU
44.1%24h Performance
Price change over last 24 hours
MRK
12.60%MU
-0.39%Price Comparison
Merck & Co., Inc.
Micron Technology, Inc.